Village Pharmacy
Form 483 issued July 11, 2016 · Allentown, New Jersey
- Inspection
- Jun 14 – Jun 22, 2016
- Investigators
- Nancy M. Espinal· Paul L. Bellamy
- Observations
- 1
- Pages
- 2
- FEI number
- 3007537202
In short: On July 11, 2016, FDA issued a Form 483 with 1 observation to Village Pharmacy in Allentown, New Jersey (FEI 3007537202) after an inspection that ran Jun 14 – Jun 22, 2016. The investigators were Nancy M. Espinal and Paul L. Bellamy. Most observations concern laboratory controls; the most-cited regulation is 21 CFR 211.166 (stability testing).
At a glance
1 of 1 observations on this 483 concern laboratory controls.
Most cited: 21 CFR 211.166(a) (1×)
What FDA observed
Preview: the opening words of each observation- 01
There is no written testing program designed to assess the stability…
This inspection in context
Nancy M. Espinal
16 documents · 2016–2022
Cites 211.192 (production record review) more than any other section. Most of their documents are for sites in New Jersey.
The firmVillage Pharmacy history
All 3 documents on file for this site, in date order, with what was cited at each inspection.
Similar 483sOther sites cited under 211.166(a)
See how FDA wrote the same problem up elsewhere.
Questions about this 483
What did FDA find at Village Pharmacy?
FDA listed 1 observation on this Form 483, mostly about laboratory controls. The most-cited regulation is 21 CFR 211.166 (stability testing). The opening words of each observation are shown on this page.
Who inspected Village Pharmacy?
Nancy M. Espinal and Paul L. Bellamy are named on this Form 483, for the inspection of Jun 14 – Jun 22, 2016. Each investigator has a profile showing what they cite most.
When was Village Pharmacy inspected by FDA?
The inspection ran Jun 14 – Jun 22, 2016, and the Form 483 is dated July 11, 2016.
How do I get the full Form 483 for Village Pharmacy?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.